Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
norUDCA versus placebo in primary sclerosing cholangitis
NL-OMON54551Phase 3Recruiting
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of norursodeoxycholic acid, sponsored by Dr. Falk Pharma GmbH. Started May 2019; status: recruiting.
02
Drugs
norursodeoxycholic acid
Beyond the preview
Go deeper on NL-OMON54551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54551.